These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30528273)

  • 1. Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery.
    Wewer Albrechtsen NJ; Geyer PE; Doll S; Treit PV; Bojsen-Møller KN; Martinussen C; Jørgensen NB; Torekov SS; Meier F; Niu L; Santos A; Keilhauer EC; Holst JJ; Madsbad S; Mann M
    Cell Syst; 2018 Dec; 7(6):601-612.e3. PubMed ID: 30528273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.
    Rega-Kaun G; Kaun C; Jaegersberger G; Prager M; Hackl M; Demyanets S; Wojta J; Hohensinner PJ
    Obes Surg; 2020 Feb; 30(2):391-400. PubMed ID: 31728904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.
    Vila G; Riedl M; Anderwald C; Resl M; Handisurya A; Clodi M; Prager G; Ludvik B; Krebs M; Luger A
    Clin Chem; 2011 Feb; 57(2):309-16. PubMed ID: 21164037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine and amphetamine regulated transcript and brain-derived neurotrophic factor in morbid obesity. One-year follow-up after gastric bypass.
    Muñoz-Rodríguez JR; Agarrado A; Martín-Fernández J; Salas E; González-Martín C; Alguacil LF
    Surg Obes Relat Dis; 2018 Nov; 14(11):1732-1739. PubMed ID: 30274741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.
    Iannelli A; Anty R; Schneck AS; Tran A; Gugenheim J
    Surgery; 2011 Mar; 149(3):364-70. PubMed ID: 20932542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects.
    Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA
    Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced glucose metabolism in cultured human skeletal muscle after Roux-en-Y gastric bypass surgery.
    Nascimento EB; Riedl I; Jiang LQ; Kulkarni SS; Näslund E; Krook A
    Surg Obes Relat Dis; 2015; 11(3):592-601. PubMed ID: 25862179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery.
    Schmatz R; Bitencourt MR; Patias LD; Beck M; da C Alvarez G; Zanini D; Gutierres JM; Diehl LN; Pereira LB; Leal CA; Duarte MF; Schetinger MR; Morsch VM
    Clin Chim Acta; 2017 Feb; 465():72-79. PubMed ID: 27986549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
    Maghsoodi N; Alaghband-Zadeh J; Cross GF; Werling M; Fändriks L; Docherty NG; Olbers T; Dew T; Sherwood RA; Vincent RP; le Roux CW
    Ann Clin Biochem; 2017 Jul; 54(4):495-500. PubMed ID: 27555664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass.
    Sans A; Bailly L; Anty R; Sielezenef I; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2017 Nov; 27(11):2940-2949. PubMed ID: 28550439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.
    Kayser BD; Lhomme M; Dao MC; Ichou F; Bouillot JL; Prifti E; Kontush A; Chevallier JM; Aron-Wisnewsky J; Dugail I; Clément K
    Int J Obes (Lond); 2017 Jun; 41(6):917-925. PubMed ID: 28280270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
    Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
    Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
    Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
    Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
    Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
    Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    Salminen P; Helmiö M; Ovaska J; Juuti A; Leivonen M; Peromaa-Haavisto P; Hurme S; Soinio M; Nuutila P; Victorzon M
    JAMA; 2018 Jan; 319(3):241-254. PubMed ID: 29340676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
    Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
    Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.